Search Results - "Varisco, Tyler J."

Outpatient opioid prescribing by Alzheimer's diagnosis among older adults with pain in United States by Huang, Yinan, Aparasu, Rajender R, Varisco, Tyler J

“…To examine opioid prescribing practices for pain in older adults with and without Alzheimer's Disease and Related Dementias (ADRD). This cross-sectional study…”
Get full text

Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis by Tata, Vaishnavi, Al Saadi, Randa, Cho, Sang Kyu, Varisco, Tyler J, Wanat, Matthew, Thornton, J Douglas

“…To understand the physician perspective on the barriers and facilitators of implementing nine different opioid risk mitigation strategies (RMS) when…”
Get full text

Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 by Varisco, Tyler J., Johnson, Michael L., Thornton, Douglas

Get full text

Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study by Olateju, Olajumoke A, Zeng, Zhen, Adenaiye, Oluwasanmi O, Varisco, Tyler J, Zakeri, Marjan, Sujit, Sansgiry S

“…The use of immunotherapy is associated with improved survival among patients with Non-Small Cell Lung Cancer (NSCLC) and has gained widespread use in its…”
Get full text

Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach by Varisco, Tyler J., Downs, Callie G., Rathburn, Kaycie R., Fleming, Marc L., Thornton, J. Douglas

“…The prevalence of opioid use and misuse in the United States contributed to 48,000 opioid related deaths in 2018. Naloxone, a potent opioid reversal agent, can…”
Get full text

Leveraging prescription monitoring program data to evaluate the implementation of buprenorphine telehealth flexibilities: An interrupted time series analysis in Texas by Chi, Whanhui, Okeke, Chijioke, Thornton, Douglas, Chen, Hua, Sadeghi, Abofazl, Varisco, Tyler J.

“…In March 2020, policy changes by the Substance Abuse and Mental Health Services Administration and the Drug Enforcement Administration aimed to maintain access…”
Get full text

Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy by Varisco, Tyler J, Fish, Hannah, Bolin, Joshua, Dadiomov, David, Hill, Lucas G, Essien, Ekere J, Wanat, Matthew A, Ginsburg, Diane, Waggener, Jeanne, Yazdanfard, Sahar, Song, Juhyeon, Chi, Whanhui, Thornton, Douglas

“…Less than half of community pharmacies in the United States stock buprenorphine products indicated for the treatment of opioid use disorder. This lack of…”
Get full text

The impact of the mainstreaming addiction treatment act and associated legislative action on pharmacy practice by Varisco, Tyler J., Wanat, Matthew, Hill, Lucas G., Thornton, Douglas

“…The recent passage of the Mainstreaming Addiction Treatment (MAT) Act will expand access to treatment for opioid use disorder (OUD) by eliminating prescriber…”
Get full text

Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents by Lyu, Ning, Abughosh, Susan, Varisco, Tyler J, Lin, Ying, Rowan, Paul J, Chen, Hua

“…Antipsychotic-associated weight gain (AAWG) is a common adverse effect of second-generation antipsychotic (SGA) medications among children and adolescents…”
Get full text

Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation Antipsychotics by Lyu, Ning, Rowan, Paul J, Abughosh, Susan, Varisco, Tyler J, Lin, Ying, Chen, Hua

“…As many as 60% of pediatric patients taking second-generation antipsychotics (SGA) experience weight gain (antipsychotic-induced weight gain). However, the…”
Get more information

Infection Risk Associated with High‐Efficacy Disease‐Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study by Li, Jieni, Hutton, George J., Varisco, Tyler J., Lin, Ying, Essien, Ekere J., Aparasu, Rajender R.

“…In patients with multiple sclerosis (MS), infections represent a significant concern, particularly given the immunomodulatory effects of disease‐modifying…”
Get full text

Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States by Li, Jieni, Hutton, George J., Varisco, Tyler J., Lin, Ying, Essien, Ekere J., Aparasu, Rajender R.

“…The optimal treatment strategy for the management of multiple sclerosis is widely discussed due to the increasing availability of high-efficacy…”
Get full text

Factors associated with the use of the prescription monitoring program by prescribers and pharmacists in Texas by Thornton, James Douglas, Varisco, Tyler J., Downs, Callie G.

“…Purpose To describe Texas Prescription Monitoring Program (PMP) use and identify predictors of PMP query for opioid and benzodiazepine prescriptions by…”
Get full text

Why the increase? Examining the rise in prescription medication expenditures in the United States between 2011 and 2020 by Chi, Whanhui, Song, Juhyeon, Yazdanfard, Sahar, Daggolu, Jerusha, Varisco, Tyler J.

“…The objective of this cross-sectional analysis was to identify determinants of increasing medicine expenditures in the US between 2011 and 2020. Prescription…”
Get full text

Using the theory of planned behavior to investigate community pharmacists’ beliefs regarding engaging patients about prescription drug misuse by Fleming, Marc L., Bapat, Shweta S., Varisco, Tyler J.

“…Opioid misuse causes over 50,000 deaths in America each year. Prescription drug monitoring program (PDMP) databases serve as a useful decision analysis tool in…”
Get full text

505-P: Real-World Use of Inclisiran in Outpatient Physician Clinics by GRAHAM, TIMOTHY E., VARISCO, TYLER J., BALLANTYNE, CHRISTIE M., ITELD, BRUCE J., SEROTA, HARVEY, MCELLIGOTT, SEAN, NIU, XIAOLI, VAN ANGLEN, LUCINDA J.

“…Objective: In clinical trials, inclisiran, a novel siRNA therapy, reduced LDL-C equally among diabetic and nondiabetic patients. This study aimed to…”
Get full text

S1366 Effectiveness of A Community-Based Inflammatory Bowel Disease Medical Home Compared to Patients not in a Medical Home by Cohen, Erica R., Ritter, Timothy E., Van Anglen, Lucinda J., Baloch, Fiza Z., Attiogbe, Kristin M., Anyanwu, Precious A., Hodnick, Brooke A., Kweit, Justin G., Varisco, Tyler J.

Get full text

Prescription drug disposal: Products available for home use by Imarhia, Fiona, Varisco, Tyler J., Wanat, Matthew A., Thornton, J. Douglas

“…Unused medications in the home are often improperly stored and may lead to unintentional harm, misuse, and diversion. Single-use disposal systems products…”
Get full text

Clinical decision making involving prescription drug monitoring programs: A factorial, vignette-based study among student pharmacists by Tata, Vaishnavi, Varisco, Tyler J., Du, Nathan, Nguyen, Jonathan, Haghparast, Parna, Thornton, James Douglas

“…Prescription drug monitoring programs (PDMPs) are state-maintained databases that providers may reference when deciding to prescribe or dispense controlled…”
Get full text

Association of cash payment with intensity of opioid prescriptions by Cho, Sang Kyu, Jun, Hankyung, Varisco, Tyler J., Lam, Jenny, Romley, John A., Li, Jieni, Thornton, J. Douglas

“…It is difficult to track use and outcomes in patients who pay cash for their prescriptions at the pharmacy. In Texas, 14% of all opioid prescriptions are paid…”
Get full text